New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 19, 2012
13:23 EDTEKDKQ, FB, CVSKodak extends printing relationship with CVS through 2016
Eastman Kodak Company (EKDKQ) announced late Friday that it will extend its relationship with CVS/pharmacy (CVS) through 2016. CVS/pharmacy operates 7,400 stores across the U.S. and is the largest customer of Kodak's Retail Systems Solutions business. CVS/pharmacy has over 15,000 Kodak Picture Kiosks in its stores. As part of this agreement, CVS/pharmacy will be upgrading and expanding its fleet of KODAK Adaptive Picture Exchange dry lab systems offerings. Following the positive customer response to the print from Facebook (FB) feature, CVS/pharmacy recently launched mobile printing from smartphones to the Kodak Kiosk. Because this new agreement resolves certain pre-chapter 11 issues between the two companies, it will be brought before the court for approval at a hearing scheduled for December 7.
News For EKDKQ;CVS;FB From The Last 14 Days
Check below for free stories on EKDKQ;CVS;FB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 14, 2014
12:26 EDTFBOn The Fly: Midday Wrap
Subscribe for More Information
10:58 EDTFBFacebook entering China a matter of when, not if, says Topeka
Subscribe for More Information
09:36 EDTFBActive equity options trading on open
Subscribe for More Information
08:59 EDTFBOn The Fly: Pre-market Movers
Subscribe for More Information
06:35 EDTFBFacebook looks to provide financial services for users, Financial Times reports
Subscribe for More Information
April 11, 2014
09:55 EDTFBFacebook bounces from early low, levels to watch
Shares began at depressed levels this morning, hitting a low of $57.31. That press down was quickly bought, with shares last at $59.62. At that price, next resistance is at $60.39. Support is at $58.51.
09:37 EDTFBActive equity options trading on open
Subscribe for More Information
06:46 EDTFBFeds warn Facebook on WhatsApp privacy, The Hill reports
The Federal Trade Commission yesterday warned Facebook not to change WhatsApp's privacy policies, according to The Hill. WhatsApp, which agreed to sell itself to Facebook earlier this year, does not collect information about its users, The Hill stated. Reference Link
06:15 EDTFBFacebook, WhatsApp deal cleared by FTC with caveat
Subscribe for More Information
April 10, 2014
17:59 EDTFBFacebook cracks down on News Feed spam
Subscribe for More Information
16:00 EDTFBOptions Update; April 10, 2014
Subscribe for More Information
15:04 EDTFBFacebook slips below the $60 area, levels to watch
Subscribe for More Information
12:11 EDTFBFacebook volatility increases on wide price movement
Subscribe for More Information
11:23 EDTCVSRite Aid hits 52-week high after results, sales view top estimates
Shares of retail drugstore Rite Aid (RAD) are rallying after the company's fourth quarter results and fiscal 2015 revenue outlook topped analysts' consensus estimates. WHAT'S NEW: This morning, Rite Aid reported fourth quarter adjusted earnings per share of 10c and revenue of $6.6B, compared to expectations of 4c and $6.54B, respectively. Q4 same store sales increased 2.1%. Rite Aid forecast FY15 EPS of 31c-42c, compared to the consensus of 35c. FY15 revenue was seen at $26B-$26.5B, ahead of the consensus $25.75B. FY15 same-store sales are expected by the company to be up 2.5%-4.5%. WHAT'S NOTABLE: Rite Aid also announced it has acquired RediClinic, which currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Rite Aid CEO John Standley said, “Our recent acquisitions of Health Dialog and RediClinic, our expanded partnership with McKesson and our continued commitment to investing in our store base have positioned us to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail healthcare company.” PRICE ACTION: In late morning trading, Rite Aid rose 71c, or about 11%, to $7.11 on more than twice its average daily trading volume. Earlier in the session, the stock hit a fresh 52-week high of $7.39. Including today's advance, the stock is up approximately 300% over the past twelve months. OTHERS TO WATCH: Other retail drugstore operators include Walgreen Company (WAG) and CVS Caremark (CVS).
10:59 EDTFBFacebook slips after Deutsche predicts smaller ad revenue beat
Subscribe for More Information
10:00 EDTFBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:37 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: SIRI RAD AAPL AMZN AA FB TSLA MRK CVX C
07:48 EDTFBFacebook strong Q1 mostly factored into consensus, says Deutsche Bank
Deutsche Bank thinks consensus estimates are catching up to the strong fundamentals at Facebook. The firm expects Facebook to report strong Q1 results, but it thinks the consensus is already factoring much of that into the numbers. As such, Deutsche said it is less optimistic going into Facebook's Q1 results than it was last quarter. The firm still considers Facebook a "must-own" and keeps a Buy rating on the stock with a $76 price target.
07:02 EDTFBFacebook upgraded to Buy from Hold at Pivotal Research
Subscribe for More Information
06:33 EDTFBTwitter upgraded to Hold from Sell at Cantor
Cantor Fitzgerald upgraded its rating on Twitter (TWTR) shares to Hold from Sell citing the recent pullback in the stock as well as the upcoming launch of new ad formats which it believes should drive monetization. Cantor maintains a $45 price target for the stock and says it continues to prefer Facebook (FB). Shares of Twitter closed yesterday up 71c to $42.49.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use